Small Animal Imaging Shared Resource
小动物成像共享资源
基本信息
- 批准号:10170627
- 负责人:
- 金额:$ 9.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcetatesAmericanAnatomyAnimal ExperimentationAnimal HousingAnimalsAreaAwardBiodistributionBudgetsCancer BiologyCancer Center Planning GrantCancer Center Support GrantChemicalsCholineClinicClinical TrialsCommunicationCompanionsComplementComprehensive Cancer CenterConsultConsultationsCyclotronsDataDevelopmentDoctor of PhilosophyDrug KineticsDrug TargetingEnsureEquipmentEthicsEvaluationFunctional disorderFundingGastroenterologyGenetic EngineeringGoalsGrantImageImaging DeviceImaging TechniquesImaging technologyImmunoPETImmunooncologyIndividualInfrastructureInterventionInvestigationIsotope LabelingIsotopesJournalsLabelLaboratoriesLeadershipLinkMagnetic Resonance ImagingMalignant NeoplasmsMedical centerMetabolismMethodsMisonidazoleMultimodal ImagingNCI Center for Cancer ResearchNational Cancer InstituteNatureNeurosciencesOpticsPET/CT scanPeer ReviewPerformancePrognostic MarkerPublicationsPublishingRadiationRadiochemistryRadioisotopesRadiolabeledReagentResearchResearch PersonnelResearch Project GrantsResource SharingResourcesSeriesServicesSmall Animal Imaging Shared ResourceSocietiesTechnologyTestingThe SunTherapeuticTherapeutic antibodiesTracerTrainingTranslational ResearchTranslationsUltrasonographyVisualizationWorkanatomic imaginganimal imaginganticancer researchbasecellular imagingclinical investigationcommunity centercostexperiencefluorodeoxyglucosegerm free conditionimage guidedimaging approachimaging biomarkerimaging modalityimprovedin vivoinsightinstrumentinstrumentationirradiationmeetingsmembermolecular imagingnovelnovel strategiesnovel therapeutic interventionnovel therapeuticsnuclear imagingoptical imagingoptoacoustic tomographyoutreachpre-clinicalprecision oncologyprogramsreceptorresponsesingle photon emission computed tomographysuccesssymposiumtheranosticstooltumortumor hypoxia
项目摘要
The Small Animal Imaging Shared Resource (SAISR) at Simmons Comprehensive Cancer Center (SCCC) is a
comprehensive small animal multimodality imaging resource that facilitates advances in the understanding of
cancer biology and the development of novel therapeutics. The SAISR enables noninvasive assessment of tumor
development, progression, and response to therapy based on multiple imaging technologies, including optical,
ultrasound, photoacoustics, MRI, CT, SPECT, and PET/CT. In addition to anatomical visualization, the SAISR
provides spatial and functional context for prognostic biomarkers and theranostic interventions. Under the
leadership of Ralph P. Mason, PhD, the SAISR facilitates and integrates pathophysiology, metabolism, and
receptor target identification with anatomical imaging. The SAISR provides SCCC investigators with assisted
and unassisted usage of imaging technologies, consultations on optimal imaging approaches, and hands-on
training in the use of imaging modalities. Since the last renewal, the SAISR has incorporated several new
approaches in order to stay at the leading edge of technology. Important enhancements in infrastructure and
capabilities include new photoacoustic tomography and access to short-lived isotopes generated by a new
cyclotron that provides multiple tracers, including 18F-MISO, 11C-acetate, and choline, that can be observed with
a new Mediso PET/CT scanner. There have also been substantial upgrades to the MRI facilities that significantly
expand the new preclinical radiation services so that investigators can use MRI and image-guided irradiation
inside a specific pathogen-free vivarium, complementing the existing instruments in conventional animal housing
areas. These capabilities of the SAISR were utilized by 41 investigators across four SCCC research programs
in 2019 and provided key data and insights to support the success of more than 30 peer-reviewed, funded
research project grants and 119 peer-reviewed publications since 2014, including work published in high-impact
journals such as Nature, Nature Communications, Nature Neurosciences, Journal of Clinical Investigation,
Gastroenterology, and the Journal of the American Chemical Society. In summary, the SAISR advances,
supports, and provides important cancer research imaging modalities to the SCCC community, enabling them
to efficiently test new therapeutic strategies in vivo as well as facilitate companion studies in clinical trials.
西蒙斯综合癌症中心 (SCCC) 的小动物成像共享资源 (SAISR) 是一个
全面的小动物多模态成像资源,有助于加深对小动物多模态成像的理解
癌症生物学和新疗法的开发。 SAISR 能够对肿瘤进行无创评估
基于多种成像技术的治疗的发展、进展和反应,包括光学、
超声、光声、MRI、CT、SPECT 和 PET/CT。除了解剖可视化之外,SAISR
为预后生物标志物和治疗诊断干预提供空间和功能背景。下
在 Ralph P. Mason 博士的领导下,SAISR 促进并整合了病理生理学、新陈代谢和
通过解剖成像进行受体靶标识别。 SAISR 为 SCCC 调查人员提供协助
成像技术的独立使用、最佳成像方法的咨询以及实践
使用成像方式的培训。自上次更新以来,SAISR 纳入了多项新内容
方法以保持技术领先地位。基础设施和技术方面的重要改进
能力包括新的光声断层扫描和获取由新的短寿命同位素
回旋加速器提供多种示踪剂,包括 18F-MISO、11C-乙酸盐和胆碱,可以用
新型 Mediso PET/CT 扫描仪。 MRI 设施也进行了大幅升级,这显着
扩大新的临床前放射服务,以便研究人员可以使用 MRI 和图像引导放射
位于特定的无病原体动物园内,补充了传统动物圈舍中的现有仪器
地区。 SAISR 的这些功能被四个 SCCC 研究项目的 41 名研究人员利用
2019 年,并提供了关键数据和见解,以支持 30 多个经过同行评审、资助的项目取得成功
自 2014 年以来获得研究项目资助和 119 篇同行评审出版物,包括在高影响力杂志上发表的作品
Nature、Nature Communications、Nature Neurosciences、Journal of Clinical Investigation 等期刊
胃肠病学和美国化学会杂志。总之,SAISR 的进展是:
支持并向 SCCC 社区提供重要的癌症研究成像模式,使他们能够
有效地在体内测试新的治疗策略并促进临床试验中的伴随研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RALPH P. MASON其他文献
RALPH P. MASON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RALPH P. MASON', 18)}}的其他基金
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease
刺激外周动脉疾病治疗性血管生成的新型纳米颗粒
- 批准号:
10462909 - 财政年份:2022
- 资助金额:
$ 9.4万 - 项目类别:
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease
刺激外周动脉疾病治疗性血管生成的新型纳米颗粒
- 批准号:
10756875 - 财政年份:2022
- 资助金额:
$ 9.4万 - 项目类别:
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease
刺激外周动脉疾病治疗性血管生成的新型纳米颗粒
- 批准号:
10616740 - 财政年份:2022
- 资助金额:
$ 9.4万 - 项目类别:
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
血管图像引导肾癌治疗反应优化 (VIGOR)
- 批准号:
10646312 - 财政年份:2020
- 资助金额:
$ 9.4万 - 项目类别:
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
血管图像引导肾癌治疗反应优化 (VIGOR)
- 批准号:
10442463 - 财政年份:2020
- 资助金额:
$ 9.4万 - 项目类别:
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
血管图像引导肾癌治疗反应优化 (VIGOR)
- 批准号:
10058644 - 财政年份:2020
- 资助金额:
$ 9.4万 - 项目类别:
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
血管图像引导肾癌治疗反应优化 (VIGOR)
- 批准号:
10171568 - 财政年份:2020
- 资助金额:
$ 9.4万 - 项目类别:
PROGNOSTIC RADIOLOGY AND THE PATHOPHYSIOLOGY OF TUMORS
预后放射学和肿瘤病理生理学
- 批准号:
8363897 - 财政年份:2011
- 资助金额:
$ 9.4万 - 项目类别:
相似海外基金
Fecal Microbiota Transfer Attenuates Aged Gut Dysbiosis and Functional Deficits after Traumatic Brain Injury
粪便微生物群转移可减轻老年肠道菌群失调和脑外伤后的功能缺陷
- 批准号:
10573109 - 财政年份:2023
- 资助金额:
$ 9.4万 - 项目类别:
Fecal Microbiota Transfer Attenuates Aged Gut Dysbiosis and Functional Deficits after Traumatic Brain Injury
粪便微生物群转移可减轻老年肠道菌群失调和脑外伤后的功能缺陷
- 批准号:
10818835 - 财政年份:2023
- 资助金额:
$ 9.4万 - 项目类别:
Trauma, the gut, and the brain: the gut microbiota-microglia axis in traumatic brain injury
创伤、肠道和大脑:创伤性脑损伤中的肠道微生物群-小胶质细胞轴
- 批准号:
10673030 - 财政年份:2022
- 资助金额:
$ 9.4万 - 项目类别:
METABOLIC REGULATION OF INFLAMMATION BY MICROBIAL-DERIVED SHORT CHAIN FATTY ACIDS
微生物衍生的短链脂肪酸对炎症的代谢调节
- 批准号:
9242634 - 财政年份:2015
- 资助金额:
$ 9.4万 - 项目类别:
Immuno-PET With Anti-PSMA 89Zr-J591 mAb For Molecular Imaging of Prostate Cancer
使用抗 PSMA 89Zr-J591 mAb 进行免疫 PET 进行前列腺癌分子成像
- 批准号:
8099997 - 财政年份:2011
- 资助金额:
$ 9.4万 - 项目类别: